Doorgaan naar hoofdnavigatie
Doorgaan naar zoeken
Ga verder naar hoofdinhoud
Sorteer per
Keyphrases
Netherlands
97%
G-formula
55%
Cardiovascular Prevention
42%
Comparative Effectiveness
40%
Monotherapy
40%
Statin Use
40%
Primary Prevention
35%
Beta-blockers
35%
Confidence Interval
31%
Population Level
30%
Inception Cohort Study
29%
Cardiovascular Mortality
26%
Obesity
26%
Partnership Status
26%
Polygenic Index
26%
Causal Inference
26%
Mortality Rate
25%
Drug Therapy
24%
Cardiac Drugs
21%
Thiazides
21%
Dutch
18%
Antidepressants
18%
Benefit Measure
18%
Population-based Study
17%
Hazard Ratio
17%
Acute Myocardial Infarction
17%
Cardiovascular Disease
16%
Antibiotics
16%
Parametric G-formula
16%
Real-world Effectiveness
15%
Longitudinal Analysis
15%
Asthma Treatment
14%
Angiotensin Receptor Blockers
14%
Vaccine Matching
13%
Prescription Sequence Symmetry Analysis
13%
Alzheimer's Disease
13%
β-adrenoceptor Antagonists
13%
Simvastatin
13%
Antihyperlipidemic
13%
Calcium Channel Blockers
13%
Clinical Trials
13%
Places of Remembrance
13%
Virus Type
13%
Hypertension
13%
Vietnam
13%
Virus Vaccine
13%
Diabetic Nephropathy
13%
Albuminuria
13%
Machine Learning
13%
Job Insecurity
13%
Pharmacology, Toxicology and Pharmaceutical Science
Statin (Protein)
100%
Cardiovascular Mortality
73%
Prevalence
53%
Cohort Study
45%
Beta Adrenergic Receptor Blocking Agent
40%
Monotherapy
40%
Cardiovascular Disease
35%
Observational Study
35%
Pharmacotherapy
31%
Asthma
29%
Clinical Trial
28%
Antihypertensive Agent
26%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
26%
Epidemiology
23%
Cardiac Agent
21%
Thiazide Diuretic Agent
21%
Angiotensin Receptor Antagonist
17%
Antilipemic Agent
15%
Randomized Controlled Trial
15%
Intervention Study
15%
Acute Heart Infarction
14%
Alzheimer's Disease
13%
Simvastatin
13%
Cardiovascular Disease
13%
Dipeptidyl Carboxypeptidase Inhibitor
13%
Calcium Channel Blocker
13%
Prospective Study
13%
Benzodiazepine
13%
Inflammation
13%
Therapeutic Drug Monitoring
13%
Albuminuria
13%
Canagliflozin
13%
SARS Coronavirus
13%
Monocyte Chemotactic Protein 1
13%
Diabetic Nephropathy
13%
Infection
13%
Antidepressant
13%
Case-Control Study
13%
Childhood Obesity
13%
Nortriptyline
13%
Multiple Sclerosis
13%
Sodium Glucose Cotransporter 2 Inhibitor
13%
Drug Administration
13%
Kidney Injury Molecule 1
13%
Pharmacoepidemiology
13%
Prostate Cancer
13%
Immunotherapy
13%
Lung Cancer
13%
Live Attenuated Influenza Vaccine
13%
Antibiotics
13%
Medicine and Dentistry
Drug Therapy
40%
Childbirth
40%
Meta-Analysis
26%
Influenza Vaccine
26%
Immunotherapy
26%
Health Care Cost
22%
Clinical Trial
19%
Observational Study
19%
Statin
19%
Cardiovascular Disease
18%
COVID-19
18%
Cost-Effectiveness Analysis
17%
Cohort Analysis
16%
Congenital Malformation
15%
Antibiotics
15%
Population Health
14%
Systematic Review
13%
Canagliflozin
13%
Mediator
13%
Adolescent
13%
Mental Health
13%
Infection
13%
Pneumococcus Vaccine
13%
Monocyte Chemotactic Protein 1
13%
Virus Typing
13%
Alcoholic Polyneuropathy
13%
Sodium Glucose Cotransporter 2 Inhibitor
13%
Childhood Obesity
13%
Liver Cirrhosis
13%
Virus Vaccine
13%
Systolic Blood Pressure
13%
Cardiovascular Disease Prevention
13%
Severe Acute Respiratory Syndrome Coronavirus 2
13%
Primary Prevention
13%
Kidney Injury Molecule 1
13%
Diabetic Nephropathy
13%
Albuminuria
13%
Cardiovascular System
13%
Pharmacoepidemiology
13%
Breast Cancer
13%
Cancer Incidence
13%
Cancer Staging
13%
Prostatectomy
13%
External Beam Radiotherapy
13%
Prostate Cancer
13%
Socioeconomic Status
13%
Lung Cancer
13%
Durvalumab
13%
Scalp
13%
Anthracycline
13%
